DESCRIPTION
This case based RSS provides Mayo staff the opportunity to discuss challenging cases on a weekly basis.  Thus providing the opportunity to improve patient outcomes through diverse discussions of patient management with a multidiscipliary audience.

TARGET AUDIENCE
This conference targets physicians, physician assistants, nurse practitioners, and nurses, as well as physicians in training, who have interest in the treatment of epilepsy patients.

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:

• Demonstrate how to interpret epilepsy testing: EEG, NPSY, PET, MRI, and WADA and when surgical intervention is appropriate.
• Identify the importance of timely and a comprehensive approach to testing, interpreting, recommending and planning epilepsy treatment 
• Assess multidisciplinary understanding and interpretation of testing and recommendations following surgical intervention
• Interpret the importance of continuation of care and follow the latest recommendations after surgical treatment
• Recognize the risk/benefit outcomes and be able to discuss with patient both before and after surgical treatment

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AOA
The American Osteopathic Association designates this program for a maximum of 1.00 AOA Category 2-A credits.

Disclosure Summary
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities.  All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.   Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.

Listed below are individuals with control of the content of this program who have disclosed...

Relevant financial relationship(s) with ineligible companies:
William Tatum, IV, D.O. – Consultant: LivaNova, Neurelis, Bioserenity, Natus Grant/Research Support: Esai, Cerevel
LivaNova, UCB Pharmaceuticals
Joseph Sirven, M.D. – Consultant: Medtronic-DMSB, Neurona-DMSB Stock, stock options, warrant: Doximity

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here. 

CE Broker Code: 21R00898-C

ATTENDANCE/CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance.  All learners are encouraged to text attendance regardless of credit needs.  This number is only used for receiving text messages related to tracking attendance.  Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows. 

COURSE DIRECTORS
William Tatum, D.O.

QUESTIONS?
Contact Christine Sutton or ph. 73-2498.